scholarly article | Q13442814 |
P50 | author | Tetsuro Ikegami | Q40311693 |
Alexander N. Freiberg | Q93156043 | ||
Nandadeva Lokugamage | Q117812116 | ||
Terry L Juelich | Q121296446 | ||
P2093 | author name string | Lihong Zhang | |
Bin Gong | |||
Jennifer K Smith | |||
Terence E Hill | |||
Olga A L Slack | |||
Hoai J Ly | |||
P2860 | cites work | The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment | Q26830833 |
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse | Q27305612 | ||
Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry | Q27478367 | ||
Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya | Q27482900 | ||
Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography | Q27487138 | ||
RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses | Q27487321 | ||
Single-particle cryo-electron microscopy of Rift Valley fever virus | Q27488344 | ||
Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA | Q27491320 | ||
Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription | Q27664646 | ||
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus | Q28486276 | ||
Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. | Q31149260 | ||
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. | Q33316823 | ||
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation | Q33406230 | ||
Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines | Q33570326 | ||
Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents. | Q33699916 | ||
Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs | Q33705717 | ||
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system | Q33755025 | ||
Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention | Q33960690 | ||
The pathogenesis of Rift Valley fever | Q34191969 | ||
Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep | Q34221766 | ||
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection | Q34260234 | ||
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. | Q35024013 | ||
Advances in Rift Valley fever research: insights for disease prevention | Q35077969 | ||
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes | Q35097798 | ||
Recent weather extremes and impacts on agricultural production and vector-borne disease outbreak patterns | Q35128140 | ||
Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy | Q35841573 | ||
Molecular epidemiology of Rift Valley fever virus | Q35849036 | ||
Potential effects of Rift Valley fever in the United States | Q36053652 | ||
Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine | Q36131361 | ||
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis | Q36397378 | ||
Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains | Q36414512 | ||
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. | Q36501630 | ||
The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function | Q36506825 | ||
Molecular biology and genetic diversity of Rift Valley fever virus | Q36652695 | ||
Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase | Q36759758 | ||
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice | Q37006803 | ||
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. | Q37254943 | ||
Rift valley fever vaccines | Q37393780 | ||
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH | Q38326807 | ||
Genetic variation among geographic isolates of Rift Valley fever virus | Q38891360 | ||
Rainfall and epizootic Rift Valley fever. | Q38963344 | ||
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies | Q39240187 | ||
NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. | Q39547955 | ||
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein | Q39686341 | ||
The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules | Q39870549 | ||
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription | Q39960501 | ||
Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination | Q40206211 | ||
Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins | Q40233812 | ||
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene | Q40311587 | ||
Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine | Q40317212 | ||
DC-SIGN as a receptor for phleboviruses | Q40318139 | ||
Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus | Q40321756 | ||
Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance | Q40327417 | ||
The pathogenesis of Rift Valley fever virus in the mouse model | Q40348320 | ||
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers | Q40397884 | ||
Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys | Q40557158 | ||
Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. | Q40579610 | ||
Improved Recovery of Rabies Virus from Cloned cDNA Using a Vaccinia Virus‐Free Reverse Genetics System | Q40629273 | ||
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. | Q40632227 | ||
Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids | Q40645618 | ||
Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle | Q40645625 | ||
Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep | Q40753243 | ||
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine | Q40759549 | ||
General aspects of the 1987 Rift Valley fever epidemic in Mauritania | Q40779661 | ||
Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes | Q40795447 | ||
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development | Q40814834 | ||
The development of a formalin-killed Rift Valley fever virus vaccine for use in man. | Q40987065 | ||
Tempering the risk: Rift Valley fever and bioterrorism | Q44936397 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Rift Valley fever | Q326638 |
attenuated vaccine | Q1810913 | ||
Rift Valley fever virus | Q14276794 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | 7262-7276 | |
P577 | publication date | 2015-05-06 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments | |
P478 | volume | 89 |